The U.S. section of Abbottep.com is a product-specific website that is NOT intended for non U.S. residents. This web content is exclusively reserved for health care professionals in the United States.

Do you wish to continue to visit the Abbottep.com U.S. section?

Get your rhythm back.

Serious heart rhythm disorders called arrhythmias, affect the lives of millions of people daily. Unfortunately, most treatments for these conditions are generic and one-size-fits-all, with mixed results.

But there’s hope.

We believe there is a better way to address serious heart rhythm disorders such as atrial fibrillation and ventricular tachycardia. Using Abbott Electrophysiology’s technology, doctors can identify the sources of arrhythmias that are unique to each person. Now treatment can be tailored to your individual needs.

Find Your Source.
Get Tailored Therapy.
Get Your Rhythm Back.

Find a doctor near you who is using the Topera Rotor Mapping System

The most common heart rhythm disorder, atrial fibrillation (AF, or afib) is a serious global public health problem which affects millions of people around the world. If left untreated, AF doubles the risk of heart-related deaths and also increases stroke risk by up to 500%. Unfortunately, although it is such a serious health problem, AF has historically been difficult to treat with an acceptable degree of success.

In response to this unaddressed need, Abbott, Inc. has developed a unique 3D analysis and mapping solutions (the Abbott 3D Mapping System), which consists of the RhythmView Workstation and FIRMap diagnostic catheter. The Abbott 3D Mapping System has been designed to enable physicians to view the electrical activity of the heart, thereby supporting the diagnosis and patient-specific treatment planning for a variety of heart arrhythmias including atrial fibrillation, atrial flutter, atrial tachycardia and ventricular tachycardia.

The Abbott 3D Mapping System received FDA Clearance in 2013 band is now in routine use at several leading medical centers throughout the United States.

Other Considerations

Unfortunately, many clinical studies have shown that traditional techniques often require multiple repeated procedures (sometimes called “touch-ups”) to achieve a reasonable rate of success. Studies have also shown that traditional techniques are much less effective with patients who have longer-term atrial fibrillation (also known as persistent Afib or permanent Afib), heart disease, and patients who have certain common conditions such as hypertension (high blood pressure), diabetes, obesity, and obstructive sleep apnea.1-5

In addition, as is the case with any invasive procedure, catheter ablation is not without risk. The rate of complications is as high as ~15%, and can include stroke, nerve damage, and damage to vital structures.6 Therefore, a solution that effectively treats Afib with a single procedure (or as few procedures as possible) is clearly attractive. Single procedure success may also be desirable from the perspective of cost savings, in that the patient is not burdened with additional co-payments or related cardiac ablation costs that are not covered by their health insurance plan.

  1. Baykaner T, Clopton P, Lalani GG et al. Targeted Ablation at Stable Atrial Fibrillation Sources Improves Success Over Conventional Ablation in High-Risk Patients: A Substudy of the CONFIRM Trial. Canadian J Cardiol 2013; 29:1218-1226.
  2. Chilukuri K, Dalal D, Gadrey S, et al. A prospective study evaluating the role of obesity and obstructive sleep apnea for outcomes after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21(5):521–525.
  3. Hoyer FF, Lickett LM, Mittmann-Braun E, et al. High prevalence of obstructive sleep apnea in patients with resistant paroxysmal atrial fibrillation after pulmonary vein isolation. J Interv Card Electrophysiol. 2010;29(1):37–41.
  4. Jongnarangsin K, Chugh A, Good E, et al. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2008; 19(7):668-672.
  5. Narayan SM, Baykaner T, Clopton P, et al. Ablation of Rotor and Focal Sources Reduces Late Recurrance of Atrial Fibrillation Compared to Trigger Ablation Alone. J Am Coll Cardiol 2014, 02.543.
  6. Packer DL, Kowal RC, Wheelan KR, et al. Cryoballoon ablation of pulmonary veins for paroxysmal AF- First results of the North American Arctic Front (STOP AF) Pivotal Trial. J Am Coll Cardiol 2013;61(16):1-11.